Structural and redox requirements for the action of anti-diabetic vanadium compounds-Reference-Cited by-同舟云学术

Structural and redox requirements for the action of anti-diabetic vanadium compounds

Published:2014 Issue:19 Volume:43 Page:6965-6972
ISSN:1477-9226
Container-title:Dalton Trans.
language:en
Short-container-title:Dalton Trans.

Author:

Yoshikawa Yutaka¹²³⁴⁵,Sakurai Hiromu⁶⁷⁸,Crans Debbie C.⁹¹⁰¹¹,Micera Giovanni¹²¹³¹⁴¹⁵,Garribba Eugenio¹²¹³¹⁴¹⁵

Affiliation:

1. Department of Health

2. Sports

3. and Nutrition

4. Faculty of Health Welfare

5. Kobe Woman's University

6. Faculty of Pharmaceutical Sciences

7. Suzuka University of Medical Science

8. Suzuka, Japan

9. Department of Chemistry

10. Colorado State University

11. Fort Collins, USA

12. Dipartimento di Chimica e Farmacia

13. and Centro Interdisciplinare per lo Sviluppo della Ricerca Biotecnologica e per lo Studio della Biodiversità della Sardegna

14. Università di Sassari

15. I-07100 Sassari, Italy

Abstract

The transformation of non-oxido V^IVto oxido V^IVspecies under physiological conditions is necessary for a vanadium compound to exhibit pharmacological anti-diabetic activity.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2014/DT/C3DT52895B

Reference84 articles.

1. Coordination chemistry of vanadium in metallopharmaceutical candidate compounds

2. Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes

3. Current state for the development of metallopharmaceutics and anti-diabetic metal complexes

4. Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components

5. Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vanadium(IV) complexes of salicylaldehyde-based furoic acid hydrazones: Synthesis, BSA binding and in vivo antidiabetic potential;Journal of Inorganic Biochemistry;2023-07

2. A Series of Non-Oxido V^IVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity;Inorganic Chemistry;2023-05-08

3. Combined effects of the lewis acidity and electric field of proximal redox innocent metal ions on the redox potential of vanadyl Schiff base complexes: an experimental and theoretical study;Dalton Transactions;2023

4. Therapeutic Properties of Vanadium Complexes;Inorganics;2022-12-06

5. Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity;Journal of Inorganic Biochemistry;2022-08